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Optical clearing has emerged as a powerful tool for volume imaging. Although
volume imaging with immunostaining have been successful in many protocols,
yet obtaining homogeneously stained thick samples remains challenging. Here,
we propose a method for label-free imaging of brain slices by enhancing the
regional heterogeneity of the optical properties using the tissue clearing princi-
ple. We used FxClear, a method for delipidation of brain tissue, to retain a larger
proportion of lipids at the white matter (WM). Furthermore, the embedding
media affected the contrasts for the lipid-rich or extracellular matrix-rich areas,
depending on their chemical properties. Thus, we tailored clearing conditions
for the enhancement of the refractive indices (RIs) differences between gray
andWM, or several pathological features. RI differences can be imaged using con-
ventional light microscopy or optical coherence tomography. We propose that
our protocol is simple, reliable, and flexible for label-free imaging, easily imple-
mentable to routine histology laboratory.
INTRODUCTION
Acquiring high-resolution images from thick samples in light microscopy has been considered to have
great limitations owing to the light scattering due to the high lipid contents and the opaque, dense extra-
cellular matrix (ECM) in thick tissues (Appel et al., 2013; Bolmont et al., 2012). Thus, the advent of tissue
clearing technique for the optical examination of thick tissues has revolutionized the 3D histological and
pathological tissue examinations (Liebmann et al., 2016; Murata et al., 2017; Nojima et al., 2017; Olson
et al., 2016; Ueda et al., 2020). There are many protocols for tissue clearing, and most of them rely on
the physical strategy to reduce light scattering, which is primarily caused by the components and arrange-
ment of materials with different refractive indices (RIs) in tissues (Chung et al., 2013; Ertürk et al., 2012;
Hama et al., 2011; Ke et al., 2013; Kuwajima et al., 2013; Lee et al., 2016a; Pan et al., 2016; Renier et al.,
2014; Susaki et al., 2014). To reduce photon scattering, most tissue clearing techniques remove lipids,
which are the main substances causing light scattering in tissue. After lipid removal, reducing the inhomo-
geneity of the tissue components by immersion in RI matching medium (Chung et al., 2013; Ertürk et al.,
2012; Hama et al., 2011; Ke et al., 2013; Kuwajima et al., 2013; Lee et al., 2016a; Pan et al., 2016; Renier
et al., 2014; Susaki et al., 2014).
The performance of these clearing techniques varies depending on the constitution of the biological tissue.
For example, tissue clearing efficiency is different across the gray matter (GM) and white matter (WM) re-
gions of the brain because the WM region contains the lipid-rich myelin sheaths. Tissues have unique sig-
natures for their macromolecule content and arrangement; therefore, their optical properties are distinct
depending on the types and conditions of the tissues (Lee et al., 2016b; Tainaka et al., 2016; Yang et al.,
2014). The contributions of these factors to the tissue-clearing efficacy are different, and the contribution
of RI matching on tissue clearing efficacy is the largest in most tissues, suggesting that the properties of
tissue ECM may be the primary factors influencing tissue clarity (Kim et al., 2018). Therefore, changes in
the architecture and biological composition of tissues under pathological conditions, such as tissue
fibrosis, can be recognized by the differential responses of the affected tissues to the tissue-clearingiScience 24, 102267, April 23, 2021 ª 2021 The Author(s).





Articleprocesses. We tested this possibility using the Active Clarity Technique (ACT) with the use of a CUBIC-
based mounting solution and found that it can detect tissue fibrosis with disorganized ECM arrangements
(Kim et al., 2018).
While the reduction in the RI difference is desirable after tissue clearing of thick specimens to obtain fluo-
rescence signals (e.g., using fluorescence proteins or dyes), RI differences have been widely used for the
detection of tissue or cell structural changes even without labeling (Habaza et al., 2017; Sung et al.,
2009; Yi and Backman, 2012). In particular, optical coherence tomography (OCT) is one of the imaging tech-
niques suitable for combined with optically cleared tissue (Baek et al., 2019; Sudheendran et al., 2010). OCT
recognizes the intrinsic scattering properties of biological tissues and has been widely used for label-free
detection of normal and pathological tissue structures (Aumann et al., 2019; Baek et al., 2019; Bizheva et al.,
2007; Brezinski et al., 1996; Hanna et al., 2005). Control of intrinsic tissue scattering through the tissue
clearing procedure enables high-resolution OCT imaging of neuronal bundles and blood vessel in thick
brain tissue without contrast agents, and enhanced OCT signals can be obtained using tissue clearing
agents (Larina et al., 2008; Ren et al., 2017; Zhong et al., 2010). However, the OCT system is not easily acces-
sible to many laboratories, and label-free imaging of thick tissues using conventional light microscopes has
been less addressed.
In this study, we aimed to further improve/examine the conditions for better recognition of the biophysical
properties of the target tissues owing to the differential lipid content, ECM content, and cell compositions
using conventional microscopic systems. In our optimized conditions, nerve bundles in the normal brain,
brain trauma-induced (TBI) tissue fibrosis, and misfolded proteins accumulate to form amyloid plaques
in the Alzheimer’s disease (AD)mouse brain were sensitively recognized without any labeling. Furthermore,
we discovered that the use of different RI adjusting media provided differential responses in biological
specimens, which will be an additional consideration for the development of diagnostic strategies based
on label-free optical imaging using the differences in RI.
RESULTS
FxClear-based tissue delipidation for the higher contrast imaging of WM
Previously, we have reported the FxClear protocol, which utilizes detergent-based delipidation of parafor-
maldehyde-fixed samples (Choi et al., 2019). Delipidation by the FxClear protocol does not allow for the
complete removal of lipids; therefore, the resultant samples were less transparent (Figure 1A). However,
they appeared to show increased contrast between the GM and lipid-rich WM compared to that of the
ACT samples that exhibited uniform clearing with more extensive delipidation (Figure 1B). We confirmed
that the less transparent regions in FxClear-processed brain slices were well-matched with the nerve bun-
dles in the WM and striatum, which are labeled by TuJ1 and MBP antibodies (Figure 1C). As a primary test,
we simply monitored how the contrast between the GM and WM changes during RI tuning. We selected
fructose and iodixanol as RI matching compounds, which are highly soluble in water and display high RI
ranging from 1.43 to 1.47. The reduction of RI of thematching solution to the suboptimal level progressively
enhanced the contrast between the transparencies of the GM and WM in both ACT- and FxClear-pro-
cessed samples followed by RI matching immersion (Figure 1D). Interestingly, when we used fructose as
an RI matching medium, the transparency of the GM and WM was significantly affected by the RI value
in FxClear-processed samples, and the transparency ratio of GM to WM (GM/WM) was larger with the
FxClear-processed brain slices than with the ACT-processed samples (Figures 1D and S1). These results
indicate that the transparency of the tissue is dependent on multiple factors including the characteristics
of tissues (GM vs. WM), tissue processing protocol (ACT vs. FxClear), and RI value.
Effects of RI matching media on the imaging of WM
Next, we tested the effects of different RI matching reagents (fructose, sucrose, histodenz, and iodixanol)
on the contrast of the transparencies between the GM and WM (Figure 2). Although we adjusted all the
media with the same RI (1.43), there were significant differences in transparency depending on the degree
of delipidation and the kinds of media, resulting in a different transparency ratio with significantly higher
ratio enhancement by RI matching with iodixanol (Figures 2A–2C and S2A). The use of iodixanol, which
showed the highest GM:WM ratio, provided a strong contrast that was sufficient for visualization of the
nerve bundles in 1 mm serial slices of the mouse brain with trans-illumination light microscopy or stereo
microscopy (Figures S2B and S2C). Iodixanol also exhibited RI-dependent transparency of the WM and
GM, similar to that by fructose, but we found that the ratio of GM/WM in different RI values remained2 iScience 24, 102267, April 23, 2021
Figure 1. FxClear-based tissue processing for label-free brain imaging
(A and B) Comparison of mouse brain slices (1 mm) processed with ACT or FxClear protocol. Digital image of optically
cleared tissue with RI matching (A) and non-matching (B).
(C) Correlative trans-illumination imaging (gray or pseudocolored in green) of FxClear-processed samples with
immunostaining of nerves (Tuj1, red) and myelin sheets (MBP, green). Scale bar = 1 mm. Inset, Scale bar = 50 mm.
(D) Images after the immersion of ACT or FxClear-processed brain slices in fructose solution with different RI (1.39–1.47)
for 1 hr. Quantification of %Transparency in gray matter (GM) and white matter (WM). Data are represented as mean G
SD. Unpaired two-tailed t-tests on data between the GM andWM, n = 6, ns, not significant, *p < 0.05, **p = 0.0033, ***p =




Articleconstant (ratio = 1.5 with ACT, 2.8 with FxClear-processed tissues; Figure S1). The hippocampal regions of
the human brain slices were also visualized with FxClear and iodixanol incubation, showing high contrast of
the nerve fiber areas (Figures 2Dand 2E). Notably, the laminar organization of the parahippocampal gyrus
can easily be determined by this method (Figure 2Eb). Collectively, these results indicate that different RI
adjusting media exhibit different features and can be chosen for reduction or enhancement of tissue RI dif-
ferences. We chose two reagents, fructose, and iodixanol, for further comparison.
Comparison of de-lipidation methods for label-free imaging with RI differences
To compare whether other de-lipidation methods used in other clearing techniques are applicable to la-
bel-free imaging, we selected two clearing methods, CUBIC and iDISCO (Renier et al., 2014; Susaki
et al., 2014). Wemodified the de-lipidation protocols from these methods to adopt them in our procedure.
In the case of CUBIC, the RI of reagent 1 is approximately 1.435 because it contains 25% N,N,N0,N0-tetra-
kis(2-hydroxypropyl) ethylenediamine which exhibits both RI adjusting and delipidation effects. Thus, we
simply used reagent 1 and incubated the brain slices for 24 hr. In the case of iDISCO, dichloromethane
(DCM) treatment is critical for the delipidation, and we dehydrated the brain slices with methanoliScience 24, 102267, April 23, 2021 3
Figure 2. RI media-dependent differences of the image contrast
(A) Images after immersion of FxClear-processed mouse brain slices in RI ( = 1.43) adjustment media (fructose, sucrose,
histodenz, and iodixanol) for 1 hr. Note that the dark structures in the images are tungsten sticks to immobilize the brain
slice during the imaging process. Scale bar = 100 mm.
(B) Quantification of %Transparency in gray matter (GM) and white matter (WM). Data are represented as mean G SD.
Unpaired two-tailed t-tests on data between the GM and WM, n = 6, **p < 0.01, ****p < 0.0001.
(C) The ratio of %Transparency of the GM andWM. Data are represented as meanG SD. One-way ANOVAwith Dunnett’s
post-hoc test (sucrose as control) on data, n = 6–7 individual RI solution, *p = 0.0263, ***p = 0.0006.
(D) Human brain slices (1 mm) containing hippocampal formation immersed in iodixanol after FxClear process.
(E) Stereo microscopic images of cleared human hippocampal tissues. Abbreviations are DG, dentate gyrus; CA1, Cornu




Articleascending series, incubated the slices with DCM briefly (15-min) and rehydrated them with methanol de-
scending series, and immersed them in iodixanol. Figure 3A shows the time spending in each treatment
step of the clearing protocols. The samples were incubated in the RI matching solutions after delipidation,
and the transmittance images were photographed using conventional light microscopes (Figure 3B). CU-
BIC- and iDISCO-processed brain slices show high tissue transparency (Figure 3C) and good contrast be-
tween GM andWM, while CUBIC-processed slices exhibited significantly inferior contrast comparing to the
FxClear- or iDISCO-processed brain slices (Figure 3D).
Optimization of the size expansion for the simple analysis
Previously, we have reported that FxClear-based delipidation by electrophoretic tissue clearing (ETC)
causes mild expansion of the tissues, and subsequent washing with phosphate-buffered saline (PBS) and
incubation with RI adjustment media (CUBIC-mount) gradually returned the samples to the original size
(Kim et al., 2018). Unlike CUBIC-mount, fructose and iodixanol showed an opposite trend in their effect
on the tissue size (Figure S3A). Incubation of ETC samples with fructose shrunk the samples considering
the original size with increasing ionic strength of the washing buffer. Iodixanol inversely expanded the tis-
sue regardless of the ionic strength of the washing buffer (Figure S3B). Considering that tissue swelling is
associated with (hyper-)hydration of the tissues, the size differences appeared to be caused by the dissim-
ilar ability of fructose and iodixanol to promote tissue hydration. Changes in the tissue size also affect the4 iScience 24, 102267, April 23, 2021
Figure 3. Comparison of delipidation methods for label-free imaging
(A) Tissue delipidation protocols of different clearing methods for 1mm-thick-brain slices. ETC, electrophoretic tissue
clearing; DCM, dichloromethane; RIs, refractive indices.
(B) Trans-illumination (upper) or stereo (bottom) microscopic images of 1-mm-thick adult mouse brain slices after
delipidation. Scale bar = 1 mm.
(C) Quantification of % transparency in gray matter (GM) and white matter (WM). Data are represented as mean G SD.
Unpaired two-tailed t-tests on data between the GM and WM, n = 6 individual method, ***p < 0.001.
(D) The ratio of % transparency of the GM andWM. Data are represented as meanG SD. One-way ANOVA with Dunnett’s




Articletransparency of the tissues (Kim et al., 2018); therefore, we used 0.13 PBS washing condition, which pro-
vided a minimal difference in the tissue sizes in the fructose and iodixanol groups.
Observation of FxClear-processed samples using OCT
Next, we quantified the light penetration depth and the contrast between the GM and WM using a lab-
made swept-source OCT system (Figure S4A). In the OCT images, the contrast between the GM and
WM was more evident in the brain slices subjected to RI matching using fructose and iodixanol than those
subjected to non-RI matching (Figure 4A). For the contrast measurement, we selected four regions from the
en-face image at a certain depth position that can cover the entire region of the GM and WM. The en-face
images of each sample were extracted from each volume data at a depth position where the GM and WM
could be clearly distinguished (Fix and FxClear: 0.26 mm from the top surface; fructose and iodixanol:
0.53 mm from the top surface). Owing to the high contrast, optical coherence microscopy (OCM) imaging
showed the clearest and highly contrasted image of fiber bundles in the specimen processed with FxClear
and immerged in iodixanol (Figures 4B and S4B). Next, we analyzed the penetration depth of light by im-
aging samples of 2 mm thickness with the depth range-enhancedOCT system. The surface of the sample in
all sub-volume from the OCT volume data was flattened, and we obtained a signal profile according to the
depth at the GM and WM regions by averaging the flattened sub-volume data in the lateral direction (Fig-
ure 4C). In this analysis, we found that the high attenuation rate of the fixed sample limited the imaging
depth to approximately 1.5 mm, whereas the FxClear process increased the imaging depth to >2.5 mm
by reducing the attenuation rate. Immersion of FxClear samples in fructose or iodixanol further reduced
the attenuation rate. Although the signal strength at the surface of the specimen was substantially lower
than that of the fixed or FxClear samples, the immersion of the samples in the RI matching solutioniScience 24, 102267, April 23, 2021 5
Figure 4. OCT and OCM images of mouse brain slices, and the results of their analysis
(A) en-face intensity (left) and pseudo-colored (right) images obtained after averaging OCT volume data in the z-direction.
(B) OCM images showing fiber bundles (image size: 320 mm 3 320 mm).
(C) Averaged signal profiles according to z-direction yellow boxed region in (A) each condition. Signal decreases from
near 0 mm owing to the light scattering by the tissue and increases from near 2 mm by noise. Sudden reductions in signal
strengths in the shaded area in the graphs indicate the bottom margin of the imaging system.
(D and E) Signal attenuation obtained from (C) and light penetration depth, respectively. The penetration depth is
defined as the depth that became 0 dB after subtracting the background signals from the averaged signal profiles. Data
are represented as meanG SD. One-way ANOVA with Dunnett’s post-hoc test (Fixation as control) on GM andWM data,
n = 3 individual condition, ns, not significant, **p < 0.01, ***p = 0.004, ****p < 0.0001.
(F) The contrast between the GM and WM. Data are represented as mean G SD. One-way ANOVA with Dunnett’s post-
hoc test (Fixation as control) on data, n = 3 individual condition, ns, not significant (p = 0.0766), ****p < 0.0001.
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Figure 5. SPIM imaging of an intact mouse brain hemisphere
(A) A sagittal view of the mouse brain hemisphere. Scale bar = 2 mm (a–c) High-magnification views of the red boxed




Articlemaintained the maximal imaging depth at approximately 2.5 mm (Figures 4D and 4E). In particular, the im-
mersion of FxClear samples in fructose or iodixanol further reduced the attenuation rate because of the
improved signal-to-noise ratio (Figure 4F). Taken together, these data suggest that RI matching including
delipidation improves imaging depth and quality in label-free imaging systems.
Autofluorescence-based imaging of FxClear-based de-lipidated whole tissue using selective
plane illumination microscope
While RI difference in FxClear-processed tissue was successfully captured and imaged with the above op-
tical devices, we wondered whether autofluorescence in the WM can be also imaged from the tissues, as
previously demonstrated with other optical clearing methods (Morozov et al., 2010; Ren et al., 2017; Renier
et al., 2016). Using a home-made selective plane illuminationmicroscope (SPIM) based on the Huisken et al.
(Huisken and Stainier, 2007), FxClear-processed entire hemi-sectioned mouse brain was successfully
imaged (Figure 5A and Video S1). We observed the fiber projection profiles in the brain. In high-resolution
imaging with SPIM, detailed structures of fibers projections in the cerebellum (Figure 5A), hippocampus
(Figure 5B), and corpus callosum (Figure 5C) were visualized (Video S2). In addition, vasculature in the ce-
rebral cortex was also noticeable (Figure 5C’), which was less profound in our previous RI-based imaging.
Thus, it appeared that autofluorescence is more sensitive to imaging vascular structures in the brain.
Hence, FxClear-based delipidated tissue could be applied for label-free 3D imaging based on their
regional differences in RI and autofluorescence.
Differentiation of injury areas via different RI adjustment media
Next, we tested whether a new protocol can be used for label-free identification of various pathological
signatures in biological tissues. We first damaged the cerebral cortex with a liquid nitrogen-frozen probe
to induce TBI, which caused rapid bleeding and progressive recovery with permanent tissue damage (Fig-
ure 6A). Our optimized protocol sensitively recognized the damaged area as early as 3 days after TBI. In
fructose medium, the TBI injury spot became dark and clearly distinguishable from the injury periphery.
The injured regions in iodixanol became brighter with spotty dark areas in TBI day 3 samples, which
were remnants of blood clots after the cardiac perfusion procedure, but the clots appeared to haveiScience 24, 102267, April 23, 2021 7
Figure 6. Label-free imaging of various pathological tissue
(A) Images of the whole (top) and sliced (bottom) mouse brain 3 and 14 days after cryogenic TBI. Scale bar = 1 mm.
(B) Brightfield images of brain slices (3- or 14-days after injury) immersed in fructose or iodixanol media. Scale bar =
500 mm.
(C) Quantification of %Transparency in GM, WM, and TBI region. Data are represented as mean G SD, One-way ANOVA
with Dunnett’s post-hoc test (WM as control) on data, n = 4–7 individual condition, *p = 0.035, **p = 0.0036, ***p < 0.001,
ns, not significant.
(D) Quantification of %Transparency ratios of GM:WM and TBI/WM in each group. Data are represented as mean G SD.
Unpaired two-tailed t-tests on data between individual pairs, n = 4–7, ns, not significant, *p < 0.05.
(E) Quantification of injury region volume change after the injury. Data are represented as mean G SD. One-way ANOVA
with Bonferroni’s multiple comparison test on data, n = 4 individual group, ns, not significant, ***p < 0.001.
(F) Immunostaining of brain slices obtained 3 or 14 days after TBI: Collagen type IV (green) and Hoechst (blue). Scale bar =
250 mm.
(G) Comparison of label-free images between the normal and 5xFAD AD model mouse brain slice. Insets show large
magnification views. Scale bar = 250 mm. Scale bar in insets = 25 mm.




Articlebeen removed in TBI day 7 samples (Figures 6A, 6B, and S6A). By 2 weeks after injury, the damaged area
became increasingly opaque, and transparency markedly reduced in both RI media (Figures 6B and 6C).
Accordingly, the ratio of the TBI regions and WM (TBI/WM) progressively decreased, whereas the GM/
WM ratio remained relatively stable (Figure 6D). Owing to the high contrast, the injured area was easily




Articlethe value of themethod for the quantitative and qualitative evaluation (Figure 6E).To associate TBI-induced
brain damage and optical alterations, we used typical markers representing the injury penumbra (accumu-
lation of activated microglia labeled with Iba1 antibody) and injury periphery (activation of astrocytes
labeled by GFAP antibody) and explored their distribution (Figure S6B). These labeling clearly distin-
guished the different sub-regions, but FxClear-based transparency imaging did not efficiently segregate
these sub-regions. Collagen type IV staining as a marker for ECM deposition/rearrangement was well-
matched with the transparency imaging, suggesting that these optical features are primarily affected by
ECM condensation (Figure 6F).
Next, we tested whether our protocol can capture the pathological features such as misfolded protein ag-
gregates, such as amyloid-beta (Ab) plaques in ADmouse brain. Figure 6G shows stitched wide-field trans-
illumination images of representative cortex coronal plane from control or 5xFAD AD model mouse brain
which were FxClear-processed and immersed in fructose media, demonstrating that Congo red-labeled
Ab-plaques were selectively found only in the AD mouse brain (Video S3). A large magnification image
clearly showed that the Congo red-labeled area can also be distinguished with dark spots in the transillu-
mination imaging (Figure 6H).
Finally, we examined whether this protocol discriminates against the implanted human glioblastoma
(GBM), which has a distinct cellular identity from nearby the mouse brain tissue. However, the implanted
GBM cells were not associated with ectopic vasculature or disruption of ECM arrangements and were
not recognized by the transparency difference in both fructose and iodixanol solutions (Figure S6C).DISCUSSION
In this study, we optimized the tissue-clearing protocol for the assessment of brain structures without spe-
cific labeling. By using simple transillumination or sophisticated imaging systems such as OCT and OCM,
we were able to discriminate nerve fiber bundles that have high lipid content and brain traumatic regions
that exhibit blood clots, misfolded protein accumulation such as Ab plaques, and deposition of ECM pro-
teins, but not implanted GBM cells. High-contrast, label-free imaging was primarily achieved with optimi-
zation of delipidation and RI adjustment conditions. To visualize the RI difference-based tissue structures,
we used three different optical methods: simple trans-illumination imaging, stereo microscopic imaging,
and OCT. Because trans-illumination or stereo microscopic imaging systems are basic equipment for
most histological laboratories, our protocol provides a simple and affordable approach to achieve label-
free information of brain structures. Loss of depth information would restrict the application of this method
to some degree, but this limitation can be overcome partially using stereo microscopy, and the use of OCT
provided the best quantifiable results. Quantification of the images obtained from OCT revealed that
FxClear with RI adjustment in iodixanol provided the best-fit contrast and sufficient imaging of 3 mm depth
without labeling. In addition, a recently introduced imaging system with solely based on the autofluores-
cence allowed axonal bundles, blood vessels, and neuronal fiber in the mouse brain and structural proteins
such as collagen, elastin in mouse lung without labeling (Morozov et al., 2010; Ren et al., 2017; Renier et al.,
2016). Similarly, we found that FxClear-based delipidated mouse brain hemisphere can also be utilized for
3D imaging with these autofluorescence signals (Figure 5). Thus, we propose that our current protocol is
flexible to obtain various label-free images by different optical devices.
Delipidation in FxClear protocol resulted in better contrast between the GM andWM than other protocols
offering better delipidation such as ACT (Lee et al., 2016a). Delipidation in FxClear protocol is executed by
electrophoresis with a buffer containing 2% sodium dodecyl sulfate (SDS) micelles, and more than 30% of
lipids remain in the tissue after the completion of electrophoresis (Choi et al., 2019). SDS cannot remove all
types of lipids equally in the biological specimen, resulting in lipid species remaining even after near
completion of the reactions. Although charged lipids such as phospholipids are easily removable by
SDS, the removal of neutral lipids and fat bodies is less effective (Jensen and Berg, 2017). Also, the dense
hydrophobic assembly of lipids reduces the surface–volume ratio, resulting in poor interaction with SDS
micelles. Therefore, both the quality and quantity of lipids in the tissue may affect the efficiency of SDS-
based delipidation, and fiber-dense regions are less efficiently resolved by SDS-based clearing. In direct
comparisons with CUBIC- and iDISCO-based delipidation procedures, the FxClear-based procedure
provided rapid, simple protocol with high RI contrast. Although CUBIC-based protocol provided slightly
inferior RI contrasts, it provides simplest single step solution. However, because RI adjustment and de-lip-




Articletime. The iDISCO-based procedure requires toxic materials and complex steps although this protocol also
provided high RI contrast comparable to the FxClear-based procedure. Therefore, the de-lipidation
methods can be selected based on the tissues and the purpose of the experiments.
We applied the FxClear technique as a strategy for designing the delipidation step optimized to enhance
the structural contrast of the tissue. To achieve label-free imaging with thick tissue via conventional micro-
scopes, we considered a chemical process, especially, RI matching. However, the RI values of the mounting
medium showed no correlation with the tissue transparency (Figure S1). The clearing performance does not
solely rely on the RI value of the medium but does reflect some chemical properties of the constituent.
Among the RI matching solution, sugar-based RI medium derives moderate tissue transparency compared
with RI media consisting of contrast reagents such as iodixanol. Iodixanol shows high hydrophilicity and
good aqueous solubility due to the dimers of non-ionic tri-iodinated aromatic compounds (Priebe et al.,
1999). Hydrophilic aromatic amides contributed to reducing the RI inhomogeneity due to the efficient sol-
vation of the protein backbone amides (Tainaka et al., 2018). On the other hand, the hydrophilicity of the
iodixanol also makes poor penetrability to the densely hydrophobic domains such asWH. Therefore, iodix-
anol seems to have a higher clearing contrast efficiency than fructose. In addition, iodixanol enhances the
hyper-hydration of tissues and mildly expands the tissue size. The hyper-hydration effect of iodixanol is
achieved by disruption of the charged ECM fiber structures and promotes media diffusivity. Conversely,
the degree of hyper-hydration is affected by the hydrophilicity of the tissue. Accordingly, the tissue-
clearing effect of themedia would be different depending on the lipid content in the region. In comparison,
fructose did not show overt tissue expansion but exhibited salt-dependent shrinkage in a given tissue.
Traumatic brain scar or Ab deposits were efficiently detected by our protocol, especially using fructose so-
lution. In the early phase of TBI, the injury core contained blood clots, the debris of dying cells and fibers,
and acutely infiltrated immune cells, whereas ECMdeposition wasmild, while the blood clots were found to
be cleared on day 7 of TBI. Fructose or iodixanol has no activity to remove heme-based pigments; there-
fore, colored blood in the tissue is recognized by trans-illumination imaging. Fructose, but not iodixanol,
efficiently detected mild ECM remodeling in the early phase (3 days) TBI samples, and low light transmis-
sion was found in the TBI core region where blood clots were not detected. In our previous study with
different protocols based on ACT clearing, we failed to achieve TBI core visualization at 3 days (Kim
et al., 2018), indicating that our current protocol with fructose is more sensitive to the detection of brain
trauma. Furthermore, our protocol provides sensitive enough contrast for recognizing micro deposits of
Ab in AD model mouse brain, suggesting the potential to use of label-free imaging for the diagnosis
purposes.Limitation of the study
Although our proposed method can be used to visualize lipid concentration and ECM deposition, which
greatly affect the light scattering of the tissue, cellular heterogeneity was not recognized because we could
not show the changes in cell composition in the TBI model or GBM implants. This may be because of the
similar optical properties of the cells, regardless of their cellular identity, and improvement of signal detec-
tion with high-end optical devices may be required. In addition, we performed our OCT and SPIM imaging
with home-made systems. Because imaging quality is greatly dependent on the optimization of imaging
equipment, it was difficult to directly compare our procedures with several previously published proced-
ures (Ren et al., 2017; Renier et al., 2016).Resource availability
Lead contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by
the Lead Contact, Woong Sun (woongsun@korea.ac.kr).
Materials availability
This study did not generate new unique reagents.
Data and code availability





All methods can be found in the accompanying transparent methods supplemental file.
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Supplemental Text and Figures 
Figure S1. Images after immersion of ACT or FxClear-processed brain slices in iodixanol 
solution with different RI (1.37–1.43) for 1 h, Related to Figure 1 
 
 
Quantification of %Transparency in gray matter (GM) and white matter (WM); Data are 
represented as mean ± SD. Unpaired two-tailed t-tests on data between the GM and WM, n = 
6, *p = 0.0153, **p = 0.0028, ****p < 0.0001. Ratios of %Transparency of the GM and WM 
were plotted at the bottom. Data are represented as mean ± SD. One-way ANOVA Dunnett’s 
multiple comparison test (RI 1.37 as control) on data, n = 5–6, ns, not significant , *p = 0.0121, 






Figure S2. Effects of contrast enhancements by FxClear-based delipidation, Related to Figure 
2   
 
(A) Comparison between delipidation methods, ACT and FxClear, and RI matching media, 
 
fructose and iodixanol. Scale bar = 1 mm. Mouse brains were coronally cut, processed and 
imaged with stereo microscopy. (B-C) Images of mouse brain slices at different levels imaged 
with transillumination (B) or with stereo microscopy (C). Scale bar = 1 mm. (Ca-Cd) The boxed 
area in C is magnified and shown in the left panel. Scale bar = 100 μm.  
 
Figure S3. Size changes of the brain slices by the FxClear, washing, and subsequent immersion 
to the RI adjustment reagents, Related to Figure 2 
 
 
(A) Experimental procedures with summary for different variables (upper panel). Lower graph 
shows the images obtained in each group. Green dotted lines indicate the outer margin of the 
slices after PBS washing step, and red dotted lines indicate the outer margin of the slices after 
 
the immersion in RI media. (B) Quantification of slice sizes. Data are represented as mean ± SD. 
Unpaired two-tailed t-tests on data between individual pairs, n = 9–12, *p = 0.0228, **p = 
0.0087, ****p < 0.0001. 
 
Figure S4. OCT system and brain tissue OCM images, Related to Figure 4 
 
 
(A) Schematic diagram of the home-made OCT system used in this study. (B) OCM 
images obtained in the area marked by the boxes (image size: 320 μm × 320 μm) 
 
Figure S5. Schematic view of the SPIM, Related to Figure 5 
 
The detailed optical setup of the 3D imaging system. This 3D imaging system consisted of 
exactly the same optical path on both sides of the sample chamber to provide uniform 
illumination. To create a light sheet collimation lens, 2D galvanometer scanners, cylindrical 
lens and illumination lens were aligned sequentially. The system also consisted of 4-color fiber 
lasers of 405 nm, 488 nm, 532 nm, and 638 nm as light sources (Coherent, Inc.). The thickness 
of the light sheet was normally 6 um, and it can be adjusted about 3~15 um depending on 
samples. The galvanometer scanners pivotally scanned to eliminate stripe artifacts in images. 
4x objective lens (NA0.13), tube lens, motorized emission filter wheel and CMOS area scan 
camera were provided to detect fluorescence images. The CMOS camera (Basler AG, Germany) 
has 8 or 12-bit pixel depth at 2.3 MP resolution.  
 
 
Figure S6. Correlative images of TBI sample and GBM xenograft model, Related to Figure 6 
 
 
(A) Correlative images of blood clots after fixation, FxClear, and RI matching in fructose (left) 
or iodixanol (right). Scale bar = 500 μm. (B) Immunofluorescence imaging of GFAP (red) and 
Iba1 (green) with nuclear counter-staining (blue, Hoechst 33342). Scale bar = 250 μm. (C) 
Correlative images of FxClear, transplanted GFP-labeled GBM, and after RI matching in 
fructose or iodixanol (left). The right image shows immunofluorescence imaging of collagen 







Animal and human specimens 
C57BL/6 male mice (6–12 weeks old) were purchased from OrientBio, Inc. Cryogenic 
traumatic brain injury (TBI) was induced as previously reported (Kim et al., 2016). Briefly, a 
metal probe (5 mm diameter) was cooled in liquid nitrogen and placed on the cranium of the 
mice for 30 s. Animals were then killed at 3 and 14 days after treatment. The mice were 
transcardially perfused with 4% paraformaldehyde (PFA, SGbio, # SG-B2197S) in PBS. The 
brains were isolated from mice and post-fixed in 4% PFA overnight at 4°C. Further, brain slices 
from 6-month-old 5xFAD AD model male mice were kindly gifted by Dr. Youngshik Choe 
(Korea Brain Research Institute). All animal husbandry, care, and euthanasia protocols were in 
accordance with guidelines from Korea University and have been approved by members of the 
Korea University Institutional Animal Care and Use Committee (KOREA-2019-0062, 
KOREA-2019-0014, KOREA-2016-0194). 
Human hippocampal tissue was obtained from a cadaver for medical student education with 
no history of brain surgery or deformity under the Korea University Anatomical Donation 
Program and treated in accordance with an accurate observance of the university guidelines. 
Human specimens were obtained with informed consent from the donator, and the procedures 
were approved by the Institutional Review Board of the Korea University College of Medicine. 
The cadaver was perfusion-fixed with 10% formalin in saline for 3 days and kept at 4°C for >2 
y. 
 
Glioblastoma mouse orthotopic xenograft model 
 
Glioblastoma (GBM) xenograft model was generated with male, 6-week-old athymic nude 
mice (Central Lab Animal) as previously reported (Byung et al., 2013; Junseong et al., 2018). 
All experimental procedures were approved by the Yonsei University College of Medicine 
Institutional Animal Care and Use Committee. Mice were anesthetized with a solution of 
Zoletil (30 mg/kg) and zylazine (10 mg/kg) delivered intraperitoneally. Dissociated U87-GFP 
cells (2×105) were implanted into the right frontal lobe of mice at a depth of 4.5 mm using a 
guide-screw system and Hamilton syringe. Mice were euthanized according to the approved 
protocol, and their brains were removed without perfusion. 
 
FxClear 
Tissue clearing by the FxClear method was performed as previously reported (Choi et al., 
2019). Briefly, fixed tissues were sliced using a tissue chopper at 1 mm thickness, and the slices 
were transferred into a cassette and placed in the electrophoretic tissue clearing (ETC) chamber 
(X-CLARITY, Logos Biosystems, # C30001) containing 2% sodium dodecyl sulfate (SDS) 
and 200 mM boric acid in H2O (pH 8.5) (Logos Biosystems, # C13001). ETC was processed 
under the following conditions: 1.5 A, 37°C for 3 h (mouse brain slice) or 24 h (human 
hippocampal tissue slice). After clearing, the samples were washed in 0.1–1× PBS overnight 
at room temperature (25℃) while shaking to remove SDS. 
 
Delipidatjon with other clearing methods  
The clearing methods including CUBIC and iDISCO followed the protocol as below (Renier 
et al., 2014; Susaki et al., 2014). For the delipidation of 1 mm-thick brain slices, the incubation 
time was empirically determined. 
 
CUBIC  ScaleCUBIC-1 reagent 1 was prepared as a mixture of 25 wt% urea (Alfa Aesar, # 
J75826), 25 wt% N,N,N’,N’-tetrakis(2-hydroxypropyl) ethylenediamine (Sigma Aldrich, # 
122262), and 15 wt% Triton X-100 (Sigma Aldrich, # T8787) in dH2O. Brain slices were 
incubated in ScaleCUBIC reagent 1 for 24 h with gentle shaking at room temperature.  
iDISCO Brain slices were dehydrated in methanol (Merck, #106009) solutions at ascending 
concentration gradient (20%, 40%, 60%, 80%, 100% and 100% in 0.01M PBS) for 1h each 
step at room temperature. Brain slices were then treated with 66% dichloromethane (DCM, 
Sigma Aldrich, # 270997)/ 33% methanol for 3 h, 100% DCM for 15 minutes twice with gentle 
shaking. DCM was washed out with 100% methanol for 1h and rehydrated with a reverse 
gradient of methanol 100%, 80%, 60%, 40%, 20% for 1 h each step at room temperature 
followed by PBS washing for 3h with gentle shaking at room temperature. Finally, samples 
were incubated in iodixanol (Sigma Aldrich, # D1556) RI matching solution with gentle 
shaking at room temperature. 
 
Congo red staining 
Congo red dye was used for detection of -pleated sheets of A plaques. Briefly, Brain slices 
were incubated in Congo red (0.01%, Sigma Aldrich, # C6767) stain for 1 h, followed by 50% 
alcohol for 3 h. All brain slices were washed with PBS and incubated in Fructose (Sigma 




After complete removal of residual SDS, FxClear-processed tissues were incubated with 
primary antibodies in 6% (w/v) bovine serum albumin (BSA, Millipore, # 82-100-6), 0.2% 
(v/v) Triton X-100 (Sigma Aldrich # T8787), and 0.01% (w/v) sodium azide (Sigma Aldrich, 
# S2002) in 0.1× PBS for 1–2 days in a 37°C shaker. The antibodies used in this study were as 
follows: Tuj1 (1:1000, Sigma Aldrich, # T8660), MBP (1:500, Abcam, # ab40390), Iba1 
(1:1000, WACO, # 019-19741), GFAP (1:1000, Invitrogen, # 13-0300), and collagen type IV 
(1:500, Millipore, # AB769). Samples were washed several times using 0.1× PBS and 
incubated with secondary antibodies (1:500, Jackson, # 712-166-150, # 705-165-147, # 715-
165-151, Invitrogen, # A21206) for 1–2 days in a 37°C shaker that matched the host of each 
primary antibody for fluorescence imaging. Samples were immersed in the RI matching 
solution and equilibrated for at least 1 h. Images were acquired using a TCS SP8 confocal laser-
scanning microscope (TCS SP8, Leica) and LSM880 Airyscan (LSM 880, Zeiss) at Ewha 
Fluorescence Core Imaging Center. Images were processed with LAS X software (Leica, 
Germany), ZEN software (Zeiss, Germany) and IMARIS program (Bitplane, Belfast, United 
Kingdom). 
 
OCT and optical coherence microscopy (OCM) 
The OCT system was built using a fiber-based Mach–Zehnder interferometer (MZI) 
(Supplemental Figure 3A). A commercial 100 kHz swept-source laser (Axsun Technologies, 
USA) was employed, and the center wavelength of the source was 1060 nm with a bandwidth 
of 100 nm. The average output power of the source was 20 mW. The sample arm comprised a 
collimator (Thorlabs Inc., # F240APC-1064, USA), a two-dimensional galvanometric scanner 
(Thorlabs Inc., # GVS002, USA), and an achromatic lens (f = 50 mm). The light backscattered 
from the sample interfered with the light that passed through the reference arm, and the 
 
interference signal was detected using a 100 MHz balanced detector (Thorlabs Inc., # 
PDB415C, USA). The detected signals were sampled using a 12-bit digitizer (Alazar 
Technologies Inc., # ATS9360, Canada) according to the k-clock signal from the source. 
However, for the light penetration depth measurement, we used another balanced detector 
(Thorlabs Inc., # PDB471C, USA) with a detection bandwidth of 400 MHz and sampled the 
interference signals according to an optical k-clock signal generated by an external MZI clock 
module to increase the depth range from 3.7 mm to 5.38 mm (Xi et al., 2010). For the light 
penetration depth measurement, 3D volume data were compensated with the normalized 
signal-to-noise ratio (SNR) graph according to the depth to consider only the light attenuation 
by the sample. Then, we selected three sub-volume regions, each from the gray matter (GM) 
and white matter (WM) of a sample. The selected regions were averaged to obtain the average 
intensity of the GM and WM, and the contrast was calculated using the following equation: 




We also observed changes in local visibility in the neuron fiber bundles using OCM, which 
is a microscopic version of OCT (Kang et al., 2020). An image of a 320 μm × 320 μm area was 
acquired using a 20× objective lens (Olympus, # UMPLFLN20XW). The imaging specimen 
was prepared at a 2 mm thickness for all groups. The sample was placed under the cover glass 
to enable immersion in distilled water. Images were acquired at a depth of approximately 100 
μm from the sample surface. 
 
Mouse brain hemisphere imaging with selective plane illumination microscope (SPIM) 
The SPIM imaging system was modified and reconstructed with reference to the previously 
reported paper (Huisken and Stainier, 2007). Imaging system consisted of exactly the same 
 
optical path on both sides of the sample chamber to provide uniform illumination (Figure S5). 
To create a light sheet collimation lens, 2D galvanometer scanners, cylindrical lens and 
illumination lens were aligned sequentially. The system also consisted of 4-color fiber lasers 
of 405 nm, 488 nm, 532 nm, and 638 nm as light sources (Coherent, Inc.). The thickness of the 
light sheet was normally 6 um, and it can be adjusted about 3~15 um depending on samples. 
The galvanometer scanners pivotally scanned to eliminate stripe artifacts in images. 4x 
objective lens (NA0.13), tube lens, motorized emission filter wheel and CMOS area scan 
camera were provided to detect fluorescence images. The CMOS camera (Basler AG, Germany) 
has 8 or 12-bit pixel depth at 2.3 MP resolution. For mouse hemisphere, a cleared mouse 
hemisphere sample was prepared with the FxClear method for 24 h delipidation. imaging was 
done at 4x magnification, 1-µm step size and a far-red (638 nm) excitation with omission of 
emission filter. The acquired images were processed software Amira (ZIB, Germany) for 3D 
image rendering. These scans can provide sufficient information regarding diverse 
neuroanatomical macrostructures (e.g. white and gray matter, hippocampal region, blood 
vessels. etc.) without external fluorescent labeling. 
 
Measurements 
Tissue transparency (%Transparency) was measured using a previously described protocol 
(Kim et al., 2018). Briefly, 1 mm-thick brain slices were imaged using a transillumination 
microscopic system (EVOS, Invitrogen, # M5000) with fixed light intensity. We measured the 
size and transparency of the slices from the images using ImageJ (public domain, National 
Institutes of Health). The gray value of the cleared sample image was used to measure tissue 




Statistical analysis was performed using GraphPad Prism 9 software (GraphPad, CA, USA). 
All data are expressed as Mean ± SD with sample sizes of n≥3, unless stated otherwise. The 
analysis methods utilized included ordinary one-way ANOVA, followed by Dunnet’s post hoc 
test or Bonferroni’s multiple comparison test. The control condition to determine the 
statistically significant differences for multiple comparisons, and unpaired two-tailed t-test for 
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